prof. Arjan van der Tol

Inequities in kidney health and kidney care

Raymond Vanholder (UGent) , Lieven Annemans, Marion Braks, Edwina A. Brown, Priya Pais, Tanjala S. Purnell, Simon Sawhney, Nicole Scholes-Robertson, Benedicte Stengel, Elliot K. Tannor, et al.

(2023) NATURE REVIEWS NEPHROLOGY. 19(11). p.694-708

Add to list

Journal Article
A1
open access

How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration : a cross-over study

Floris Vanommeslaeghe (UGent) , Iván Josipovic (UGent) , Matthieu Boone (UGent) , Arjan van der Tol (UGent) , Annemieke Dhondt (UGent) , Wim Van Biesen (UGent) and Sunny Eloot (UGent)

(2021) CLINICAL KIDNEY JOURNAL. 14(7). p.1752-1759

Add to list

Journal Article
A1
open access

Supplemented ERA-EDTA registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe

Vianda S. Stel, Rianne W. de Jong, Anneke Kramer, Anton M. Andrusev, José M. Baltar, Myftar Barbullushi, Samira Bell, Pablo Castro de la Nuez, Harijs Cernevskis, Cécile Couchoud, et al.

(2021) KIDNEY INTERNATIONAL. 100(1). p.182-195

Add to list

Farmacotherapeutische actualiteit

Arjan van der Tol (UGent) , Lucas Van Bortel (UGent) and Thierry Christiaens (UGent)

(2020) TIJDSCHRIFT VOOR GENEESKUNDE. 76(5). p.209-211

Add to list

A call for harmonization of European kidney care : dialysis reimbursement and distribution of kidney replacement therapies

Arjan van der Tol (UGent) , Vianda S Stel, Kitty J Jager, Norbert Lameire (UGent) , Rachael L Morton, Wim Van Biesen (UGent) , Raymond Vanholder (UGent) and [missing] European Kidney Health Alliance (EKHA)

(2020) NEPHROLOGY DIALYSIS TRANSPLANTATION. 35(6). p.979-986

Add to list

The impact of dialysis modalities and reimbursement fees on public health care expenditure in European countries with higher and lower GDPC

Arjan van der Tol (UGent) , Norbert Lameire (UGent) , Rachael L Morton, Wim Van Biesen (UGent) and Raymond Vanholder (UGent)

(2019) NEPHROLOGY DIALYSIS TRANSPLANTATION. 34(suppl. 1).

Add to list

An international analysis of dialysis services reimbursement

Arjan van der Tol (UGent) , Norbert Lameire (UGent) , Rachael L Morton, Wim Van Biesen (UGent) and Raymond Vanholder (UGent)

(2019) CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 14(1). p.84-93

Add to list

Should screening of renal markers be recommended in a working population?

Arjan van der Tol (UGent) , Wim Van Biesen (UGent) , Guy De Groote, Paul Verbeke, Frans Vermeiren, Kathleen Eeckhaut and Raymond Vanholder (UGent)

(2014) INTERNATIONAL UROLOGY AND NEPHROLOGY. 46(8). p.1601-1608

Add to list

PhD Thesis
open access

Pitfalls of using microalbuminuria as a screening tool to identify subjects with increased risk for kidney and cardiovascular disease

Arjan van der Tol (UGent)

(2014)

Add to list

Journal Article
A1
open access

Statin use and the presence of microalbuminuria : results from the ERICABEL trial : a non-interventional epidemiological cohort study

Arjan van der Tol (UGent) , Wim Van Biesen (UGent) , Steven Van Laecke (UGent) , Kris Bogaerts, Koen De Lombaert, Hans Warrinnier and Raymond Vanholder (UGent)

(2012) PLOS ONE. 7(2).

Academic Bibliography

prof. Arjan van der Tol

Inequities in kidney health and kidney care

How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration : a cross-over study

Supplemented ERA-EDTA registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe

Farmacotherapeutische actualiteit

A call for harmonization of European kidney care : dialysis reimbursement and distribution of kidney replacement therapies

The impact of dialysis modalities and reimbursement fees on public health care expenditure in European countries with higher and lower GDPC

An international analysis of dialysis services reimbursement

Should screening of renal markers be recommended in a working population?

Pitfalls of using microalbuminuria as a screening tool to identify subjects with increased risk for kidney and cardiovascular disease

Statin use and the presence of microalbuminuria : results from the ERICABEL trial : a non-interventional epidemiological cohort study

Contents

Support

Contact